Skip to main content

Table 9 Urinary biomarkers

From: A single-blinded, single-centre, controlled study in healthy adult smokers to identify the effects of a reduced toxicant prototype cigarette on biomarkers of exposure and of biological effect versus commercial cigarettes

Biomarker

Number and volume of aliquots

4-Aminobiphenyl, 3-Aminobiphenyl,

2 aliquots of 12 mL each

o-Toluidine, 2-Aminonaphthalene

OH-PAHs suite

2 aliquots of 12 mL each

Nicotine + 5

2 aliquots of 6 mL each

3-HPMA, HMPMA, CEMA

2 aliquots of 3 mL each

MHBMA

2 aliquots of 3 mL each

Total NNAL, NNN, NAB and NAT

2 aliquots of 10 mL each

F2-isoprostane (8-iso-PGF2 Type III)

2 aliquots of 6 mL each

F2-isoprostane (8-iso-PGF2 Type VI)

2 aliquots of 6 mL each

11-dehydrothromboxane B2

2 aliquots of 3 mL each

Urine mutagenicity

1 aliquots of 300 mL each

8-OHdG

2 aliquots of 1.5 mL each

Cis-thymidine glycol

2 aliquots of 1.5 mL each

  1. OH-PAH, phenolic polycyclic aromatic hydrocarbons.3-HPMA, 3-Hydroxypropylmercapturic acid.
  2. HMPMA, 3-hydroxy-1-methylpropylmercapturic acid. CEMA, 2-cyanoethylmercapturic acid.
  3. MHBMA, monohydroxy-3-butenylmercapturic acid. NNAL, 4-(methylnitrosamino-1-(3-pyridyl)-1-butanol.
  4. NNN, N-nitrosonornicotine. NAB, N-nitrosoanabasine. NAT, N-nitrosoanatabine.
  5. 8-OhdG, 8-Oxo-2′-deoxyguanosine.